How Generative AI and Wearables Are Redefining
Real-World Evidence (RWE) and Market Access in 2025
In 2025, the healthcare industry is undergoing a profound transformation, driven by the dynamic convergence of Generative AI and wearable technologies. These innovations are not just influencing how data is gathered they are fundamentally reshaping the way Real-World Evidence (RWE) is created, interpreted, and utilized to drive market access strategies.
At WLCUS we are excited to spotlight these cutting-edge trends at our upcoming Global RWE & Market Access Summit 2025, bringing together industry leaders to explore the future of healthcare innovation.
Why Real-World Evidence is Central to Healthcare Innovation?
Real-World Evidence has moved from a supporting role to center stage. Sourced from electronic health records (EHRs), insurance claims, patient registries, and increasingly, wearable device data, RWE is:
- Supporting regulatory approvals (FDA, EMA, PMDA)
- Fueling value-based care models and reimbursement decisions
- Informing Health Technology Assessments (HTAs)
- Enhancing personalized treatment pathways
- Strengthening commitments to health equity and ESG standards
Clinical trials remain vital, but they are no longer sufficient alone. In 2025, real-world data fills critical gaps to reflect true patient experiences and outcomes.
The New Role of Generative AI in Real-World Evidence
Generative AI is a game-changer for RWE:
- Speed and scale: AI can process millions of health records and medical publications in minutes.
- Predictive modeling: Simulating outcomes using synthetic patient data helps optimize trial designs.
- Personalized insights: Tailoring treatments based on individual behaviors captured through real-world monitoring.
- Efficient reporting: AI-assisted generation of regulatory submissions saves time and reduces costs.
These exciting topics will be explored in depth during our summit sessions focused on the impact of AI in healthcare data science.
Wearables and Digital Health - A New Frontier for Data Collection
Wearable devices like Apple Watch, Fitbit, and specialized medical-grade biosensors are generating continuous health data across diverse patient populations. In 2025:
- Regulators are accepting wearable data as part of submission packages.
- Payers are demanding real-world effectiveness proven by wearable data.
- Providers are using real-time monitoring to deliver precision care.
Metrics like heart rate variability, glucose monitoring, sleep quality, and physical activity are now directly influencing decentralized clinical trials (DCTs) and real-world evidence models a hot topic that our summit will address through case studies and expert panels.
Market Access in 2025: Data-Driven, Patient-Centered
Market access today demands:
- Clear demonstration of real-world outcomes.
- Outcome-based contracts tied to actual patient improvements.
- Proof of commitment to health equity and diverse population insights.
- Ethical and transparent use of AI in healthcare.
At the Global RWE & Market Access Summit 2025, top industry leaders will share strategies on navigating this complex, rapidly evolving environment.
The Future is Now
Generative AI and wearable technologies are redefining the standards for Real-World Evidence and market access in healthcare. Organizations that embrace these innovations today will lead the future of patient-centric, data-driven care.
We invite you to join us at the Global RWE & Market Access Summit 2025 to explore these transformational trends firsthand, network with global experts, and future-proof your RWE and market access strategies.
👉 Register now and be part of healthcare’s next revolution! Global RWE & Market Access Summit 2025